Vimarsana
Biggest News Aggregation in the World

Sarah Thailing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sarah Thailing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sarah Thailing Today - Breaking & Trending Today

Poseida Therapeutics to Present at the 65th ASH Annual Meeting and Exposition - Vimarsana News

Poseida Therapeutics to Present at the 65th ASH Annual Meeting and Exposition

SAN DIEGO - Poseida Therapeutics, Inc. , a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, today announced the acceptance...

Poseida Therapeutics Announces Virtual 2023 Annual Meeting of Stockholders - Vimarsana News

Poseida Therapeutics Announces Virtual 2023 Annual Meeting of Stockholders

SAN DIEGO, June 1, 2023 /PRNewswire/ -- Poseida Therapeutics, Inc. , a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases,... | June 1, 2023

Poseida Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference - Vimarsana News

Poseida Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference

SAN DIEGO, Sept. 7, 2022 /PRNewswire/ --Poseida Therapeutics, Inc. , a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell...

Poseida Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference - Vimarsana News

Poseida Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference

/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform...

Poseida Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference - Vimarsana News

Poseida Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference

/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform...